These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12578306)

  • 1. Development of a non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine.
    Mayr A
    New Microbiol; 2003 Jan; 26(1):7-12. PubMed ID: 12578306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of of non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine].
    Mayr A
    Berl Munch Tierarztl Wochenschr; 2001; 114(5-6):184-7. PubMed ID: 11413711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taking advantage of the positive side-effects of smallpox vaccination.
    Mayr A
    J Vet Med B Infect Dis Vet Public Health; 2004 Jun; 51(5):199-201. PubMed ID: 15330977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune recognition of poxviral vaccine vectors.
    Lousberg EL; Diener KR; Brown MP; Hayball JD
    Expert Rev Vaccines; 2011 Oct; 10(10):1435-49. PubMed ID: 21988308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal poxvirus vaccines: a comprehensive review.
    Bhanuprakash V; Hosamani M; Venkatesan G; Balamurugan V; Yogisharadhya R; Singh RK
    Expert Rev Vaccines; 2012 Nov; 11(11):1355-74. PubMed ID: 23249235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental detection of the paraspecific effects of purified and inactivated poxviruses].
    Mayr A; Büttner M; Wolf G; Meyer H; Czerny C
    Zentralbl Veterinarmed B; 1989 Mar; 36(2):81-99. PubMed ID: 2473583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study of postvaccinal immunity to sheep-pox].
    Fassi-Fehri M; El-Harrak M; Johnson D; Abbadi M; El-Idrissi AH
    Ann Rech Vet; 1984; 15(1):59-64. PubMed ID: 6091523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Present state of preclinical research on the efficacy and safety of para immunity inducers from poxviruses. A study of the literature].
    Mayr B; Mayr A
    Tierarztl Prax; 1995 Dec; 23(6):542-52. PubMed ID: 8585070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A live attenuated virus vaccine against sheep pox.
    Sólyom F; Perenlei L; Roith J
    Acta Vet Acad Sci Hung; 1981; 28(4):389-98. PubMed ID: 6269410
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the immunizing ability of some attenuated strains of sheep pox virus and of a sensitizing vaccine].
    Achour HA; Bouguedour R; Bouhbal A; Guechtouli A; Aouissat M
    Rev Sci Tech; 2000 Dec; 19(3):773-83. PubMed ID: 11107620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sheep-pox vaccine prepared from formaldehyde inactivated virus adsorbed to aluminium hydroxide gel.
    Sólyom F; Perenlei L; Roith J
    Acta Microbiol Acad Sci Hung; 1982; 29(2):69-75. PubMed ID: 6291337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against pox diseases under immunosuppressive conditions.
    Mayr A; Danner K
    Dev Biol Stand; 1978; 41():225-34. PubMed ID: 223909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Culture of the sheep pox virus on cells: application to vaccination and immunity control].
    Ramisse J; Asso J; Hassani A; Anane O; Jemli J
    Rev Elev Med Vet Pays Trop; 1978; 31(1):11-9. PubMed ID: 213823
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences between extracellular and intracellular forms of poxvirus and their implications.
    Boulter EA; Appleyard G
    Prog Med Virol; 1973; 16():86-108. PubMed ID: 4356899
    [No Abstract]   [Full Text] [Related]  

  • 15. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
    Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
    Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?
    Bukreyev A; Belyakov IM
    Expert Rev Vaccines; 2002 Aug; 1(2):233-45. PubMed ID: 12901562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys.
    Goletti D; Macchia I; Leone P; Pace M; Sernicola L; Pavone-Cossut MR; Maggiorella MT; Cafaro A; Ensoli B; Titti F
    Med Sci Monit; 2006 Oct; 12(10):BR330-40. PubMed ID: 17006396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The paraspecific immune defense: possibilities and limits].
    Mayr A
    Tierarztl Prax; 1993 Feb; 21(1):1-9. PubMed ID: 8470097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vero cell derived combined vaccine against sheep pox and Peste des Petits ruminants for sheep.
    Chaudhary SS; Pandey KD; Singh RP; Verma PC; Gupta PK
    Vaccine; 2009 Apr; 27(19):2548-53. PubMed ID: 19428860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.